...
首页> 外文期刊>Journal of chromatography, A: Including electrophoresis and other separation methods >Quantification of cannabinoids and their free and glucuronide metabolites in whole blood by disposable pipette extraction and liquid chromatography-tandem mass spectrometry
【24h】

Quantification of cannabinoids and their free and glucuronide metabolites in whole blood by disposable pipette extraction and liquid chromatography-tandem mass spectrometry

机译:通过一次性移液器萃取和液相色谱-串联质谱法定量全血中的大麻素及其游离和葡萄糖醛酸代谢产物

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Identifying recent cannabis intake is confounded by prolonged cannabinoid excretion in chronic frequent cannabis users. We previously observed detection times <= 2.1 h for cannabidiol (CBD) and cannabinol (CBN) and Delta(9)-tetrahydrocannabinol (THC)-glucuronide in whole blood after smoking, suggesting their applicability for identifying recent intake. However, whole blood collection may not occur for up to 4h during driving under the influence of drugs investigations, making a recent-use marker with a 6-8 h detection window helpful for improving whole blood cannabinoid interpretation. Other minor cannabinoids cannabigerol (CBG), Delta 9-tetrahydrocannabivarin (THCV), and its metabolite 11-nor-9-carboxy-THCV (THCVCOOH) might also be useful. We developed and validated a sensitive and specific liquid chromatography-tandem mass spectrometry method for quantification of THC, its phase I and glucuronide phase II metabolites, and 5 five minor cannabinoids. Cannabinoids were extracted from 200 mu L whole blood via disposable pipette extraction, separated on a C-18 column, and detected via electrospray ionization in negative mode with scheduled multiple reaction mass spectrometric monitoring. Linear ranges were 0.5-100 mu g/L for THC and 11-nor-9-carboxy-THC (THCCOOH); 0.5-50 mu g/L for 11-hydroxy-THC (11-OH-THC), CBD, CBN, and THC-glucuronide; 1-50 mu g/L for CBG, THCV, and THCVCOOH; and 5-500 mu g/L for THCCOOH-glucuronide. Inter-day accuracy and precision at low, mid and high quality control (QC) concentrations were 95.1-113% and 2.4-8.5%, respectively (n =25). Extraction recoveries and matrix effects at low and high QC concentrations were 54.0-84.4% and -25.8-30.6%, respectively. By simultaneously monitoring multiple cannabinoids and metabolites, identification of recent cannabis administration or discrimination between licit medicinal and illicit recreational cannabis use can be improved. Published by Elsevier B.V.
机译:在长期频繁使用大麻的人中,识别最近的大麻摄入量与延长的大麻素排泄混淆。我们先前观察到吸烟后全血中大麻二酚(CBD)和大麻酚(CBN)和Delta(9)-四氢大麻酚(THC)-葡萄糖醛酸的检测时间<= 2.1小时,表明它们可用于识别近期摄入量。但是,在药物调查的影响下,驾驶过程中长达4小时可能不会出现全血收集,这使得具有6-8小时检测窗口的最近使用标记有助于改善全血大麻素的解释。其他次要大麻素大麻二酚(CBG),Delta 9-四氢大麻酚(THCV)及其代谢物11-nor-9-羧基-THCV(THCVCOOH)也可能有用。我们开发并验证了一种灵敏且特异的液相色谱-串联质谱法,用于定量四氢大麻酚,其I相和葡糖醛酸苷II相代谢产物以及5种5种次要大麻素。大麻素通过一次性移液器从200μL全血中提取,在C-18色谱柱上分离,并通过负离子模式下的电喷雾电离检测,并进行定时多反应质谱监测。 THC和11-nor-9-羧基-THC(THCCOOH)的线性范围为0.5-100μg / L;对于11-羟基-THC(11-OH-THC),CBD,CBN和THC-葡萄糖醛酸,0.5-50μg/ L; CBG,THCV和THCVCOOH为1-50克/升;和THCCOOH-葡糖醛酸的5-500μg/ L。在低,中和高质量控制(QC)浓度下,日间准确性和精密度分别为95.1-113%和2.4-8.5%(n = 25)。在低和高QC浓度下,提取回收率和基质效应分别为54.0-84.4%和-25.8-30.6%。通过同时监测多种大麻素和代谢物,可以改善最近使用大麻的鉴定或合法药用大麻和非法娱乐性大麻使用之间的区别。由Elsevier B.V.发布

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号